Zelin Gu

991 total citations · 1 hit paper
16 papers, 766 citations indexed

About

Zelin Gu is a scholar working on Molecular Biology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Zelin Gu has authored 16 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Epidemiology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Zelin Gu's work include Liver Disease Diagnosis and Treatment (7 papers), Alcohol Consumption and Health Effects (5 papers) and Gut microbiota and health (4 papers). Zelin Gu is often cited by papers focused on Liver Disease Diagnosis and Treatment (7 papers), Alcohol Consumption and Health Effects (5 papers) and Gut microbiota and health (4 papers). Zelin Gu collaborates with scholars based in China and United States. Zelin Gu's co-authors include Wenke Feng, Yunhuan Liu, Fengyuan Li, Craig J. McClain, Shirish Barve, Liqing He, Xiang Zhang, Tuo Shao, Mengwei Jiang and Lihua Zhang and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

Zelin Gu

15 papers receiving 759 citations

Hit Papers

Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibro... 2019 2026 2021 2023 2019 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zelin Gu China 11 405 334 152 130 89 16 766
Sang Hak Han South Korea 16 495 1.2× 397 1.2× 208 1.4× 183 1.4× 72 0.8× 35 932
Gladys Ferrere France 9 462 1.1× 503 1.5× 194 1.3× 157 1.2× 134 1.5× 12 980
Shaoqi Yang China 13 409 1.0× 204 0.6× 86 0.6× 108 0.8× 32 0.4× 37 768
Haripriya Gupta South Korea 18 582 1.4× 474 1.4× 111 0.7× 263 2.0× 112 1.3× 36 917
Cuiqing Zhao China 13 509 1.3× 367 1.1× 251 1.7× 170 1.3× 35 0.4× 28 890
Cen Li China 18 289 0.7× 201 0.6× 56 0.4× 82 0.6× 43 0.5× 59 861
Yuanyuan Wang China 15 299 0.7× 264 0.8× 43 0.3× 62 0.5× 80 0.9× 72 787
Adebowale Adeyemi United States 7 593 1.5× 418 1.3× 64 0.4× 164 1.3× 207 2.3× 14 1.1k
Oriol Juanola Spain 15 298 0.7× 417 1.2× 40 0.3× 132 1.0× 192 2.2× 22 756

Countries citing papers authored by Zelin Gu

Since Specialization
Citations

This map shows the geographic impact of Zelin Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zelin Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zelin Gu more than expected).

Fields of papers citing papers by Zelin Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zelin Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zelin Gu. The network helps show where Zelin Gu may publish in the future.

Co-authorship network of co-authors of Zelin Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Zelin Gu. A scholar is included among the top collaborators of Zelin Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zelin Gu. Zelin Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Shao, Tuo, Zelin Gu, Yuzhu Liu, et al.. (2025). Long-term in vivo monitoring of transplanted mesenchymal stromal cells in colitis mice with magnetic particle imaging. EBioMedicine. 116. 105775–105775. 4 indexed citations
2.
4.
Zhao, Runan, et al.. (2023). Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances. Journal of Materials Chemistry B. 12(1). 13–38. 24 indexed citations
5.
Jiang, Mengwei, Fengyuan Li, Yunhuan Liu, et al.. (2022). Probiotic‐derived nanoparticles inhibit ALD through intestinal miR194 suppression and subsequent FXR activation. Hepatology. 77(4). 1164–1180. 36 indexed citations
6.
Gu, Zelin, et al.. (2022). A novel bioactive postbiotics: from microbiota-derived extracellular nanoparticles to health promoting. Critical Reviews in Food Science and Nutrition. 63(24). 6885–6899. 11 indexed citations
7.
Gu, Zelin, Fengyuan Li, Yunhuan Liu, et al.. (2021). Exosome-Like Nanoparticles From Lactobacillus rhamnosus GG Protect Against Alcohol-Associated Liver Disease Through Intestinal Aryl Hydrocarbon Receptor in Mice. Hepatology Communications. 5(5). 846–864. 65 indexed citations
8.
Li, Fengyuan, Zelin Gu, Mengwei Jiang, et al.. (2021). 75 EXOSOME-LIKE NANOPARTICLES FROM LACTOBACILLUS RHAMNOSUS GG PROTECT AGAINST ALCOHOLIC LIVER DISEASE THROUGH INTESTINAL AHR IN MICE. Gastroenterology. 160(6). S–16.
9.
Li, Fengyuan, Jenny Chen, Yunhuan Liu, et al.. (2021). Deficiency of Cathelicidin Attenuates High-Fat Diet Plus Alcohol-Induced Liver Injury through FGF21/Adiponectin Regulation. Cells. 10(12). 3333–3333. 11 indexed citations
10.
Li, Fengyuan, Cuiqing Zhao, Tuo Shao, et al.. (2020). Cathelicidin‐related antimicrobial peptide alleviates alcoholic liver disease through inhibiting inflammasome activation. The Journal of Pathology. 252(4). 371–383. 22 indexed citations
11.
Liu, Qi, Yunhuan Liu, Fengyuan Li, et al.. (2019). Probiotic culture supernatant improves metabolic function through FGF21-adiponectin pathway in mice. The Journal of Nutritional Biochemistry. 75. 108256–108256. 51 indexed citations
12.
Gu, Zelin, Yanfeng Wu, Yu Wang, et al.. (2019). Lactobacillus rhamnosus Granules Dose-Dependently Balance Intestinal Microbiome Disorders and Ameliorate Chronic Alcohol-Induced Liver Injury. Journal of Medicinal Food. 23(2). 114–124. 35 indexed citations
13.
Liu, Yunhuan, Kefei Chen, Fengyuan Li, et al.. (2019). Probiotic Lactobacillus rhamnosus GG Prevents Liver Fibrosis Through Inhibiting Hepatic Bile Acid Synthesis and Enhancing Bile Acid Excretion in Mice. Hepatology. 71(6). 2050–2066. 263 indexed citations breakdown →
14.
Gu, Zelin, et al.. (2019). Probiotics for Alleviating Alcoholic Liver Injury. Gastroenterology Research and Practice. 2019. 1–8. 30 indexed citations
15.
Shao, Tuo, Cuiqing Zhao, Fengyuan Li, et al.. (2018). Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. Journal of Hepatology. 69(4). 886–895. 196 indexed citations
16.
Gu, Zelin, et al.. (2013). FcγRI is required for TGFβ2-treated macrophage-induced tolerance. Immunobiology. 218(9). 1200–1206. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026